More ETHEX Generic Medicine Recalls

ETHEX Corporation has recalled more lots of generic medicines because some pills may be oversized.  In addition to previous recalls of morphine sulfate and dextroamphetamine, the new recall includes two cardiac drugs and additional lots and dosages of morphine and dextroamphetamine. There is a possibility…

Read Full Post

FDA: ETHEX Recalls Dextroamphetamine Sulfate 5mg Tablets

ETHEX Corporation has recalled three lots of dextroamphetamine sulfate 5mg tablets which may contain oversized pills and up to twice the dose of the drug. ETHEX discovered a small number of oversized tablets in lots that had not yet been distributed.  While there have been…

Read Full Post

Jalapeno Pepper Genetic Match for Salmonella Strain

The FDA announced yesterday, July 21, 2008, that they have traced the Salmonella SaintPaul strain that has caused a widespread outbreak of gastrointestinal illness in nearly 1,300 identified people in 43 states.  A sample of jalapeno pepper found in a produce distribution center in McAllen,…

Read Full Post

Deaths from Salmonella Outbreak Continue to Rise

More than 810 cases of salmonella related to tomatoes have been reported to the FDA, according to the latest update on June 27th. Ninety-five people have been hospitalized.  Cases have been identified in 36 states and the District of Columbia.  While there have not been…

Read Full Post

FDA Warns of Online Cancer Fraud

The FDA has developed a message for consumers warning them of fraudulent online cancer cures. They are frequently offered as dietary supplements or natural treatments. Medicines and devices intended to treat cancer must gain FDA approval before they are marketed. The agency’s review process helps…

Read Full Post

Ethex morphine tablets recalled

The FDA has announced a voluntary recall of a single lot of morphine sulfate 60 mg extended release tablets by Ethex Corporation. Lot No. 91762, distributed between April 16th and April 27th of 2008, contained at least one over-sized tablet that might contain up to…

Read Full Post

FDA Approves Entereg to Improve Post-Surgery Bowel Function

The FDA has approved Entereg® (alvimopan) to speed the restoration of normal bowel function after intestinal surgery. However, the approval comes with a Risk Evaluation and Mitigation Strategy (REMS) to be sure that the benefits of using Entereg outweigh any potential risks.  Under the REMS,…

Read Full Post
Page 7 of 7« First...34567